Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.
about
The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manToll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developmentsInteraction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.Alum, an aluminum-based adjuvant, induces Sjögren's syndrome-like disorder in miceType I interferon receptor deficiency prevents murine Sjogren's syndromeNatural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse modelFrankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathwayInnate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in miceWhen killers become helpers.Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.Flagellar filament structural protein induces Sjögren's syndrome-like sialadenitis in mice.Innate immunity in Sjögren's syndrome.Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models.Genetic associations to germinal centre formation in primary Sjogren's syndrome.
P2860
Q26825196-DB1B0518-5FA3-44C0-ADCF-B1A559CDF6DAQ28067211-E259D9C1-AF89-4472-8E25-73C242D84B15Q30300132-A9087AFD-B343-47F1-A612-7EFAFC2BC546Q30405839-5202EDB7-77FC-4FAC-89C6-E82EC6354D49Q30413385-F1658754-7438-4F08-9C79-B321BE2B7B6CQ30425772-1B541EBC-0B7E-4F5A-A2A1-C93FAD2F585CQ35023259-207F19B1-F844-4B82-AF2E-186E926510AEQ36017886-A2632B47-67A6-453A-AE0D-F6F7F45779CAQ36380242-A3DB0F3C-1D70-44A7-8136-30195ACC8195Q36407966-5B885E16-ECFA-4E81-95C0-5317706E74B5Q37060371-AB2D9B00-FB22-435F-93C3-A14ED534B0A4Q37640242-1113C60D-C1C0-4FEA-ABB6-5D167D7AA8CEQ38840238-9D23B9A4-EE00-4561-9F79-A24E065D380CQ38988639-3A896C4C-424F-45C7-A118-551ED14933ABQ39232871-2C8F9BC9-FDE4-47AE-893F-5A3CB71AEE75Q41848000-5539D890-D620-49B8-BF5A-CBDA5EE79E60Q43676169-2DB73C0B-1459-468B-B0D5-2AC2BD5184ED
P2860
Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of innate immunity ...... ögren's syndrome-like disease.
@ast
Activation of innate immunity ...... ögren's syndrome-like disease.
@en
type
label
Activation of innate immunity ...... ögren's syndrome-like disease.
@ast
Activation of innate immunity ...... ögren's syndrome-like disease.
@en
prefLabel
Activation of innate immunity ...... ögren's syndrome-like disease.
@ast
Activation of innate immunity ...... ögren's syndrome-like disease.
@en
P2093
P2860
P1433
P1476
Activation of innate immunity ...... ögren's syndrome-like disease.
@en
P2093
H Bagavant
S-R Nandula
U S Deshmukh
Y M Scindia
P2860
P304
P356
10.1111/J.1601-0825.2011.01839.X
P577
2011-08-04T00:00:00Z